⌘K

Home/Insiders/Alspaugh Jonathan

AJ

SEC Insider//CIK 0001868112

Alspaugh Jonathan

CIK 00018681121 companyAUSTIN, TX

Transactions

10

Companies

1

Filings

8

CIK

0001868112

Recent Transactions

10 trades

Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2023-06-22+19,787,969→ 19,787,969 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2023-02-23+640,000→ 640,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2022-08-23+130,000→ 130,000 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2022-03-11$2.08/sh+75,000→ 165,372 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2022-02-17+170,000→ 170,000 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-12-09$3.72/sh+50,000→ 90,372 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-08-18$6.72/sh+7,200→ 40,372 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-08-17$6.50/sh+23,392→ 33,172 total
Purchase
Spyre Therapeutics, Inc.$SYRE
Common Stock
2021-08-16$6.37/sh+9,780→ 9,780 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2021-07-06+160,000→ 160,000 total

Companies

1

Spyre Therapeutics, Inc.
Chief Financial Officer
$SYRE

Recent Filings

8

Address

C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100

AUSTIN, TX, 78746

View on SEC.gov